FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003276119> ?p ?o ?g. }

• W2003276119 abstract "BACKGROUND: The overall survival and disease-free rates for Acute Myelogenous Leukemia (AML) patients treated with the gold-standard therapy comprised of Cytarabine (Ara-C) and Daunorubicin (DNR) remain significantly low. Camptothecins are potent anticancer drugs that confer their cytotoxic effect by interfering with Topoisomerase-I (Top1). Semi-synthetic camptothecin analogues have been used in the past to treat AML patients with relatively low response rates. Here, we examined the anti-leukemia activity of AR-67, a novel camptothecin analogue, alone or in combination with standard agents for the treatment of AML. METHODS: The anti-leukemia activity of AR-67, TPT, Ara-C and DNR was studied in HL60, KG1 and K562 cells and in primary leukemia cell cultures after exposure to increasing drug concentrations for 48 hours. Cell proliferation was determined using a colorimetric assay (MTT) assay and IC50s were obtained using nonlinear-regression analysis. Drug combination treatments were assessed for synergy. The expression of Top1, phosphohistone (γ-H2AX), Bcl-2 and c-PARP were evaluated using biochemical assays. RESULTS: The potency of AR-67 was in the nM range in the leukemic cell lines. Consistent with the lower proliferation rates of primary cells grown in culture, their IC50 values were variable and in the µM range. IC50s estimated for TPT were higher than the respective ones for AR-67. The IC50 values for Ara-C and DNR were in the μM range for the HL60, K562 and primary cells, and higher than the ones for AR-67. However, the KG-1 cell line appeared to be more sensitive to the AML gold standard therapy, but not as sensitive as to AR-67. AR-67 treatment decreased Top1 expression, increased γ-H2AX expression in a concentration-dependent manner suggesting removal of DNA-Top1 complexes and formation of double strand DNA breaks. Induction of apoptosis was manifested by decreased Bcl-2 and increased c-PARP expression suggesting a caspace-3 mediated effect. AR-67 combination treatments that included DNR and Ara-C showed synergy in HL60 cells. Additionally, pretreatment with Ara-C revealed synergy between AR-67 and DNR in both the KG1 and K562 cells, accompanied by increased γ-H2AX and c-PARP expression. CONCLUSIONS: Our results indicate AR-67 as a potent anticancer agent that induces DNA damage and apoptosis. Using in vitro leukemia models we have shown that AR-67 is a potentially efficacious agent when combined with standard agents for the treatment of AML and may benefit AML patients resistant to Ara-C. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 3547. doi:10.1158/1538-7445.AM2011-3547" @default.
• W2003276119 created "2016-06-24" @default.
• W2003276119 creator A5008062466 @default.
• W2003276119 creator A5013968242 @default.
• W2003276119 creator A5084489076 @default.
• W2003276119 date "2011-04-15" @default.
• W2003276119 modified "2023-09-25" @default.
• W2003276119 title "Abstract 3547: In vitro and ex vivo anti-leukemia activity of AR-67, a novel lipophilic camptothecin" @default.
• W2003276119 doi "https://doi.org/10.1158/1538-7445.am2011-3547" @default.
• W2003276119 hasPublicationYear "2011" @default.
• W2003276119 type Work @default.
• W2003276119 sameAs 2003276119 @default.
• W2003276119 citedByCount "1" @default.
• W2003276119 countsByYear W20032761192021 @default.
• W2003276119 crossrefType "proceedings-article" @default.
• W2003276119 hasAuthorship W2003276119A5008062466 @default.
• W2003276119 hasAuthorship W2003276119A5013968242 @default.
• W2003276119 hasAuthorship W2003276119A5084489076 @default.
• W2003276119 hasConcept C171122931 @default.
• W2003276119 hasConcept C185592680 @default.
• W2003276119 hasConcept C203014093 @default.
• W2003276119 hasConcept C2778041864 @default.
• W2003276119 hasConcept C2778461978 @default.
• W2003276119 hasConcept C2778903051 @default.
• W2003276119 hasConcept C2779682216 @default.
• W2003276119 hasConcept C2780783641 @default.
• W2003276119 hasConcept C2781021840 @default.
• W2003276119 hasConcept C55493867 @default.
• W2003276119 hasConcept C62112901 @default.
• W2003276119 hasConcept C71924100 @default.
• W2003276119 hasConcept C98274493 @default.
• W2003276119 hasConceptScore W2003276119C171122931 @default.
• W2003276119 hasConceptScore W2003276119C185592680 @default.
• W2003276119 hasConceptScore W2003276119C203014093 @default.
• W2003276119 hasConceptScore W2003276119C2778041864 @default.
• W2003276119 hasConceptScore W2003276119C2778461978 @default.
• W2003276119 hasConceptScore W2003276119C2778903051 @default.
• W2003276119 hasConceptScore W2003276119C2779682216 @default.
• W2003276119 hasConceptScore W2003276119C2780783641 @default.
• W2003276119 hasConceptScore W2003276119C2781021840 @default.
• W2003276119 hasConceptScore W2003276119C55493867 @default.
• W2003276119 hasConceptScore W2003276119C62112901 @default.
• W2003276119 hasConceptScore W2003276119C71924100 @default.
• W2003276119 hasConceptScore W2003276119C98274493 @default.
• W2003276119 hasLocation W20032761191 @default.
• W2003276119 hasOpenAccess W2003276119 @default.
• W2003276119 hasPrimaryLocation W20032761191 @default.
• W2003276119 hasRelatedWork W1591903789 @default.
• W2003276119 hasRelatedWork W1982067801 @default.
• W2003276119 hasRelatedWork W1984390136 @default.
• W2003276119 hasRelatedWork W2026243259 @default.
• W2003276119 hasRelatedWork W2054935251 @default.
• W2003276119 hasRelatedWork W2087964934 @default.
• W2003276119 hasRelatedWork W2314178748 @default.
• W2003276119 hasRelatedWork W2319283415 @default.
• W2003276119 hasRelatedWork W2342670512 @default.
• W2003276119 hasRelatedWork W2345630854 @default.
• W2003276119 hasRelatedWork W2505100803 @default.
• W2003276119 hasRelatedWork W2555412546 @default.
• W2003276119 hasRelatedWork W2564561218 @default.
• W2003276119 hasRelatedWork W2566482266 @default.
• W2003276119 hasRelatedWork W2570300042 @default.
• W2003276119 hasRelatedWork W2571611675 @default.
• W2003276119 hasRelatedWork W2588530553 @default.
• W2003276119 hasRelatedWork W2930083104 @default.
• W2003276119 hasRelatedWork W3007201866 @default.
• W2003276119 hasRelatedWork W65177702 @default.
• W2003276119 isParatext "false" @default.
• W2003276119 isRetracted "false" @default.
• W2003276119 magId "2003276119" @default.
• W2003276119 workType "article" @default.